Neuropathic pain inhibitor, RAP-103, is a potent inhibitor of microglial CCL1/CCR8

M. Noda,Daichi Tomonaga,Kota Kitazono,Yusaku Yoshioka,Jiadai Liu,Jean‐Philippe Rousseau,R. Kinkead,M. Ruff,C. Pert
DOI: https://doi.org/10.1016/j.neuint.2017.12.005
IF: 4.297
2017-12-01
Neurochemistry International
Abstract:
What problem does this paper attempt to address?